Jane Chang

Jane is the sole proprietor of JC Reg Tox where she consults for small biotech companies developing drugs that save or improve quality of life in patients. She has more than 40 years of hands-on experience and proven records in basic research, study directing and monitoring, reporting and publishing, teamwork and leadership in product development, as well as regulatory requirements, submissions and interactions with regulatory agencies. She has held multiple key positions at Wyeth and AstraZeneca, where she was the toxicology project leader for an approved biologic oncology drug and an inhaled small molecule combination drug. Jane also contributed to the registrational approval of a gout drug by Ardea. Prior to joining the pharmaceutical industry, Jane worked as a research toxicologist in the personal care and crop protection industries after completing postdoctoral training in inhalation toxicology at Chemical Industry Institute of Toxicology (CIIT). She received her Ph.D. in Environmental Toxicology from the Johns Hopkins School of Hygiene and Public Health. Jane has been a full member of the Society of Toxicology since 1985 and a member of the American Board of Toxicology since 1990.